Trials / Unknown
UnknownNCT05183698
Point-spectroscopy Trial
Spectroscopic Assessment of Autofluorescent Signatures of Tissue in and Around Wounds Identified by MolecuLight i:X Imaging Device
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- MolecuLight Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
Evaluation and characterization of autofluorescence signals of tissue in and around wounds as identified by MolecuLight fluorescence image.
Detailed description
Evaluate and characterize autofluorescence signals of tissue components in and around wounds identified by MolecuLight FL images using a point spectrometer. The fluorescence spectroscopy data will yield quantitative spectral information, including the relative intensity and emission peak of the biological autofluorescence signatures.
Conditions
Timeline
- Start date
- 2022-01-10
- Primary completion
- 2022-05-10
- Completion
- 2022-12-10
- First posted
- 2022-01-11
- Last updated
- 2022-01-11
Source: ClinicalTrials.gov record NCT05183698. Inclusion in this directory is not an endorsement.